Metastasis-directed therapies (MDTs) could serve as an intermediate treatment between surveillance and systemic androgen deprivation therapy (ADT)
This episode of the BE KIND ALWAYS PODCAST includes a chat with Dr. Larry Bans about getting in for your annual exam and how important early detection really is.
Is one of these tests right for you? Do you even need one?
Light shed on the nmCRPC treatment landscape and notable ongoing trials examining antiandrogens in different settings
Paul L. Nguyen, MD, discusses the role of radiation in high-risk prostate cancer and ongoing research efforts.
Read this OncLive article by Hayley Virgil.